GE HealthCare Technologies (GEHC) News
Market Cap: $31.17B
Avg Volume: 4.31M
Industry: Medical - Healthcare Information Services
Sector: Healthcare
Should You Buy, Sell, or Hold GE Healthcare Before Q1 Earnings?
GEHC Q1 results are likely to reflect strong growth in Imaging, Ultrasound, and AI, fueled by robust procedure volumes and global partnerships despite China headwinds.
zacks.com
Read More
Stay Ahead of the Game With GE HealthCare (GEHC) Q1 Earnings: Wall Street's Insights on Key Metrics
Besides Wall Street's top -and-bottom-line estimates for GE HealthCare (GEHC), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2025.
zacks.com
Read More
GE HealthCare management to present at upcoming investor conferences
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) is announcing that members of its management team will present at the following upcoming investor conferences. Bank of America Securities Healthcare Conference in Las Vegas, NV – May 13, 2025 at 10:00 am CT / 11:00 am ET Goldman Sachs 46th Annual Global Healthcare Conference in Miami, FL – June 10, 2025 at 9:00 am CT / 10:00 am ET Webcasts of these events can be accessed at the GE HealthCare website: https://investor.gehealthcare.com/news-e.
businesswire.com
Read More
Here's Why You Should Hold the GEHC Stock in Your Portfolio for Now
GE HealthCare's continued focus on innovations, acquisitions and partnerships raises optimism about the stock.
zacks.com
Read More
GE HealthCare to feature latest advancements in diagnostic accuracy and patient-centered breast care at SBI 2025 Breast Cancer Imaging Symposium
COLORADO SPRINGS, Colo.--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC), a global leader in breast health technology, will feature its latest advancements in diagnostic accuracy and patient-centered breast care during the 2025 Society of Breast Imaging Symposium in Colorado Springs, Co., April 24-27, 2025. This year's showcase will feature new innovations designed to improve breast cancer detection, streamline workflows, and enhance overall patient care. Mammography innovations streamline exam w.
businesswire.com
Read More
GE HealthCare to announce first quarter 2025 results on April 30, 2025
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) will announce its first quarter 2025 financial results before the market opens on Wednesday, April 30, 2025. The GE HealthCare management team will also host a conference call and webcast at 8:30 a.m. Eastern Time / 7:30 a.m. Central Time on that same day, which will be a live webcast and accessible at https://investor.gehealthcare.com/news-events/events. The earnings release, accompanying financial information, and webcast replay also will.
businesswire.com
Read More
GE HealthCare (GEHC) Surges 10.6%: Is This an Indication of Further Gains?
GE HealthCare (GEHC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
zacks.com
Read More
Cincinnati Children's and GE HealthCare build collaborative research program to drive pediatric imaging innovation
CHICAGO--(BUSINESS WIRE)--Cincinnati Children's and GE HealthCare (Nasdaq: GEHC) will form a strategic research program focused on driving clinical and technical research to advance innovation for pediatric care delivery across modalities, including magnetic resonance imaging (MRI), ultrasound, molecular imaging (MI), and computed tomography (CT). The research program will establish the first pediatric Care Innovation Hub nationwide, representing a new model established by GE HealthCare and Cin.
businesswire.com
Read More
GE HealthCare: Looking Healthier Here
GE HealthCare, spun off from GE in early 2023, has seen its stock trade between $60-$90, now trading at the low end of the range. The company reports nearly $20 billion in sales and is gradually posting higher margins, looking to expand these to the 20% mark. For 2025, GE HealthCare expected 2-3% sales growth and a 40-50 basis point EBIT margin improvement, with free cash flow over $1.75 billion.
seekingalpha.com
Read More
GE HealthCare names Jeannette Bankes president and CEO, Patient Care Solutions
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC), a leading global healthcare solutions provider, announced the appointment of Jeannette Bankes as president and CEO, Patient Care Solutions, effective May 1, 2025. Peter Arduini, president and CEO, GE HealthCare, said, “Jeannette is a proven leader who has diverse and deep experience at publicly traded companies in the healthcare industry. We proudly welcome her to the company and are confident that she has the expertise to move Patient Car.
businesswire.com
Read More
Why GE HealthCare Technologies Stock Fell Today
Shares in GE HealthCare Technologies (GEHC -9.60%) were down 9.5% at 1 p.m. today. The decline follows the U.S.'s wide-scale implementation of tariffs.
fool.com
Read More
GE HealthCare and FPT Expand Strategic Partnership to Drive AI-Powered Healthcare Innovation
HANOI, Vietnam--(BUSINESS WIRE)-- #FPT--Global IT firm FPT and GE HealthCare announced a Strategic Cooperation Agreement, expanding their commercial alliance to advance product strategy and development, and establish an FPT Competency Center in Vietnam. This deepening collaboration reflects a strategic shift from project-based engagement to a long-term alliance aimed at accelerating the adoption of AI-driven solutions, enhancing operational efficiency, and improving patient care. As part of the commer.
businesswire.com
Read More
GEHC Stock Gains Following Buyout Completion to Boost Its PDx Arm
GE HealthCare aims to expand its existing footprint and offerings in Japan, as well as enhance patient access to next-generation radiopharmaceuticals via its latest acquisition.
zacks.com
Read More
GEHC Stock May Rise as Revolution Vibe CT Enhances Imaging Tech
GE HealthCare introduces Revolution Vibe CT, a cutting-edge imaging system designed to enhance diagnostic precision, improve workflow efficiency, and expand accessibility.
zacks.com
Read More
GE HealthCare's Latest Product Launch to Boost Cardiology Care
GEHC's latest commercial launch of Flyrcado and the grant of pass-through status by CMS aim to serve a wider patient pool across the United States.
zacks.com
Read More
GE HealthCare Completes Acquisition of Nihon Medi-Physics (NMP), a Leading Radiopharmaceutical Company in Japan
CHICAGO--(BUSINESS WIRE)--GE HealthCare Technologies Inc. (GE HealthCare or the Company) (Nasdaq: GEHC) has completed its acquisition of the remaining 50% stake in Nihon Medi-Physics Co., Ltd (NMP), from Sumitomo Chemical, giving it full ownership. As part of GE HealthCare, NMP can further build on its expertise in developing and manufacturing proprietary and in-licensed radiopharmaceuticals used in single photon emission computed tomography (SPECT) and positron emission tomography (PET) molecu.
businesswire.com
Read More
Down 13% to 41%, These 3 Nvidia Partners Are Raging Buys
Data center equipment maker Vertiv (VRT -2.65%), healthcare technology specialist GE HealthCare Technologies (GEHC -2.08%), and electrical protection and connection products company nVent Electric (NVT -3.11%) are all Nvidia collaborators, and they all focus on the AI growth opportunity. Here's why and how these stocks are great buys right now.
fool.com
Read More
GE HealthCare unveils Revolution™ Vibe CT system with Unlimited One-Beat Cardiac imaging and AI Solutions
CHICAGO--(BUSINESS WIRE)--At the American College of Cardiology 2025 meeting, GE HealthCare (Nasdaq: GEHC) will proudly introduce Revolution™ Vibe,i a new computed tomography (CT) system with Unlimited One-Beat Cardiac imaging to deliver consistent, high-quality images for patients, even in challenging cases like atrial fibrillation and heavily calcified coronaries. Combined with the company's impressive ECG-less Cardiac, TrueFidelity DL, SnapShot Freeze 2, and Effortless Workflow's AI-powered.
businesswire.com
Read More
GE HealthCare announces cash dividend for first quarter of 2025
CHICAGO--(BUSINESS WIRE)--The Board of Directors of GE HealthCare Technologies Inc. (Nasdaq: GEHC) today declared a cash dividend of $0.035 per share of Common Stock for the first quarter of 2025 payable on May 15, 2025 to all shareholders of record as of April 25, 2025. About GE HealthCare Technologies Inc. GE HealthCare is a trusted partner and leading global healthcare solutions provider, innovating medical technology, pharmaceutical diagnostics, and integrated, cloud-first AI-enabled soluti.
businesswire.com
Read More
ACC 2025: GE HealthCare announces the U.S. launch of pivotal innovations that will help transform the cardiology care pathway
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced the U.S. launch of Flyrcado™ (flurpiridaz F 18) injection at the 2025 American College of Cardiology (ACC) Annual Scientific Session & Expo, taking place March 29-31 in Chicago. Additionally, the company will showcase new AI-powered innovations, reflecting its strategy to leverage AI to help increase efficiency and enable seamless integration of data across the cardiology care pathway. GE HealthCare has been investing in.
businesswire.com
Read More
3 Hidden Gem AI Stocks to Buy That You Might Never Have Thought Of
Many top artificial intelligence (AI) stocks have come into the spotlight and produced monster gains in recent years. These gains have been great for their longer-term shareholders, of course, but they've also left the stocks trading at expensive and forward-looking valuations -- levels high enough that some risk-averse investors may be avoiding the theme altogether.
fool.com
Read More
US population is aging: here are the top 2 stocks set to benefit
The US population is aging. In fact, according to Mizuho analysts, those aged 75 and more will likely make up about 10% of the country's population by the end of this decade.
invezz.com
Read More
GEHC Stock Falls Despite New Launch to Boost Breast Cancer Diagnosis
GE HealthCare aims to deliver optimal outcomes with its innovative, patient-friendly and efficient AI-driven technology via its latest product offering.
zacks.com
Read More
Here's Why You Should Hold GEHC Stock in Your Portfolio for Now
GE HealthCare's continued focus on innovations, acquisitions and partnerships raises optimism about the stock.
zacks.com
Read More
GE HealthCare launches AI-driven, patient-friendly Invenia ABUS Premium to accelerate scanning and drive early cancer detection in dense breasts
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) announced the launch of Invenia™ Automated Breast Ultrasound (ABUS) Premium, the latest 3D ultrasound offering advanced artificial intelligence (AI) and innovative features to drive faster*, reproducible supplemental screening and streamline exam readings on patients with dense breasts. Approximately 71% of cancers occur in dense breasts.1 According to studies across the U.S. and Europe, 40% of women2 and 70% of Asian women3 have dense brea.
businesswire.com
Read More
3 Under-the-Radar Value AI Stocks With Market-Beating Potential
These three stocks aren't conventionally seen as artificial intelligence (AI) stocks, yet AI is a critical part of the growth story of HVAC and building controls/software company Johnson Controls (JCI 1.58%), and electrical solutions company nVent Electric (NVT 2.45%). Meanwhile, integrating AI-enabled solutions is the key to long-term growth at GE HealthCare (GEHC 0.26%).
fool.com
Read More
GE HealthCare and NVIDIA reimagine diagnostic imaging with autonomous X-ray and ultrasound solutions
SAN JOSE, Calif.--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced a collaboration with NVIDIA at GTC 2025, expanding the existing relationship between the two companies to focus on pioneering innovation in autonomous imaging, beginning with autonomous X-ray technologies and autonomous applications within ultrasound. GE HealthCare has been at the forefront of medical technology innovation with a series of “firsts” that date back more than a century, starting with the invention of i.
businesswire.com
Read More
GE HealthCare expands invasive cardiology solutions portfolio with AltiX AI.i for elevated experience in catheterization lab and electrophysiology procedures
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced the launch of the AltiX AI.i edition of Mac-Lab™, CardioLab™ and ComboLab™. The AltiX AI.i editions are designed to improve the user experience, elevating workflow in the cardiac catheterization (cath) lab and supporting even the most complex electrophysiology (EP) procedures. These latest editions offer new features that can streamline workflow and enhance interoperability, while upholding strong cybersecurity standards. Ca.
businesswire.com
Read More
NVIDIA's AI Speeds Up MedTech's Digital Boom: 3 Stocks in Focus
RMD, GEHC and MDT are expected to thrive as NVIDIA and other AI leaders' MedTech ventures accelerate digital adoption within the space.
zacks.com
Read More
Goldman Sachs Gains Confidence In Market Rebound, Upgrades GE Healthcare Amid China Recovery Hopes
Last week, U.S. President Donald Trump vowed to impose a 25% tariff on imported goods from Mexico and Canada and to double tariffs on those from China to 20%.
benzinga.com
Read More
GEHC Stock May Gain as Genesis Portfolio Expands Cloud Offerings
GE HealthCare unveils Genesis, a cloud-based imaging portfolio designed to enhance healthcare efficiency, streamline data access, and drive digital transformation.
zacks.com
Read More
Earnings Growth & Price Strength Make GE HealthCare Technologies (GEHC) a Stock to Watch
Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.
zacks.com
Read More
GEHC Stock May Rise on Freelium Magnet Launch, Boosts MR Access
GE HealthCare unveils Freelium, a next-gen sealed magnet platform designed to revolutionize MR imaging with minimal helium usage.
zacks.com
Read More
GE HealthCare names new president and CEO, China
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC), a leading global healthcare solutions provider, today announced that Yihao Zhang, president and CEO, China, will retire from the company effective July 1, 2025. Will Song, a Johnson & Johnson veteran for over 20 years, has been named GE HealthCare's new president and CEO, China, and will join the company on April 1, 2025, ahead of leading the region starting July 1 following Yihao's departure. Yihao's planned retirement allowed GE Heal.
businesswire.com
Read More
GE HealthCare Technologies (GEHC) is a Top-Ranked Value Stock: Should You Buy?
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
zacks.com
Read More
Enlitic and GE HealthCare to Collaborate to Redefine Imaging Data Migration and Cloud Solutions for Enterprise Imaging
FORT COLLINS, Colo., Feb. 17, 2025 (GLOBE NEWSWIRE) -- Enlitic, Inc., (ASX:ENL) a leader in healthcare imaging data solutions, and its subsidiary Laitek, announces a collaboration with GE HealthCare, a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator.
globenewswire.com
Read More
Why Is GE HealthCare Stock Trading Soaring On Thursday?
On Thursday, GE HealthCare GEHC reported fourth-quarter adjusted EPS of $1.45, up from $1.18 a year ago, beating the consensus of $1.26.
benzinga.com
Read More
GE HealthCare Technologies Inc. (GEHC) Q4 2024 Earnings Call Transcript
GE HealthCare Technologies Inc. (NASDAQ:GEHC ) Q4 2024 Earnings Conference Call February 13, 2025 8:30 AM ET Company Participants Carolynne Borders - Chief IR Officer Peter Arduini - President and CEO Jay Saccaro - VP and CFO Conference Call Participants Anthony Petrone - Mizuho Financial Group Craig Bijou - BofA Securities Vijay Kumar - Evercore ISI Matt Taylor - Jefferies Joanne Wuensch - Citi Larry Biegelsen - Wells Fargo David Roman - Goldman Sachs Robbie Marcus - JPMorgan Operator Good day, and thank you for standing by. Welcome to the GE HealthCare Fourth Quarter and Full Year 2024 Earnings Conference Call.
seekingalpha.com
Read More
GE HealthCare Q4 Earnings Beat Estimates, Sales Miss, Net Margin Rises
GEHC's fourth-quarter results reflect strength in the Advanced Visualization Solutions and Pharmaceutical Diagnostics segments. The bottom line improves on better pricing.
zacks.com
Read More
GE HealthCare Tops Q4 EPS Forecasts
Medical technology and pharmaceutical diagnostics specialist GE HealthCare Technologies (GEHC -1.30%) reported mixed financial results for the fourth quarter of 2024 on Thursday, Feb. 13. Adjusted earnings per share (EPS) of $1.45 were a significant beat over the anticipated $1.27.
fool.com
Read More
GE HealthCare Technologies (GEHC) Surpasses Q4 Earnings Estimates
GE HealthCare Technologies (GEHC) came out with quarterly earnings of $1.45 per share, beating the Zacks Consensus Estimate of $1.26 per share. This compares to earnings of $1.18 per share a year ago.
zacks.com
Read More
GE HealthCare forecasts upbeat 2025 profit on steady medical device demand
GE HealthCare Technologies on Thursday forecast annual profit above Wall Street estimates, counting on strong demand for its medical devices in markets such as the U.S. to offset weakness in China.
reuters.com
Read More
GE HealthCare Posts Q4 Profit Above Expectations
GE HealthCare (GEHC) reported better-than-expected fourth-quarter profit on Thursday, while sales were in line with analysts' estimates.
investopedia.com
Read More
GE Healthcare's business grows with boost from imaging and diagnostic drug units
The company said it was “pleased with
marketwatch.com
Read More
GE HealthCare Stock Rises on Strong Earnings and Outlook
The medical imaging company issues solid guidance for 2025.
barrons.com
Read More
GE HealthCare reports fourth quarter and full year 2024 financial results
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today reported financial results for the fourth quarter and full year ended December 31, 2024. GE HealthCare President and CEO Peter Arduini said, “We were pleased with the strong momentum in orders, backlog and book-to-bill that we saw in the fourth quarter. We also continued to deliver revenue growth driven by demand in our Advanced Visualization Solutions and Pharmaceutical Diagnostics businesses, with overall strength in the U.S., and r.
businesswire.com
Read More
GEHC Q4 Earnings: Will Robust Procedures Help Offset Chinese Weakness?
GEHC's fourth-quarter results are likely to reflect mixed segmental performance in imaging, advanced visualization solutions and patient care. Pharma is likely to have been the key driver.
zacks.com
Read More
PAHC vs. GEHC: Which Stock Is the Better Value Option?
Investors interested in Medical - Products stocks are likely familiar with Phibro Animal Health (PAHC) and GE HealthCare Technologies (GEHC). But which of these two stocks is more attractive to value investors?
zacks.com
Read More
What Analyst Projections for Key Metrics Reveal About GE HealthCare (GEHC) Q4 Earnings
Get a deeper insight into the potential performance of GE HealthCare (GEHC) for the quarter ended December 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
zacks.com
Read More
GEHC Stock May Rise With $138M Investment in Cork Facility Expansion
GE HealthCare invests $138M to expand its Cork facility to enhance manufacturing capacity for life-saving imaging contrast media and strengthen its global supply chain.
zacks.com
Read More
GEHC Stock May Gain on FDA's Nod for the Updated Voluson Expert Series
GE HealthCare launches the enhanced Voluson Expert Series to advance women's health with faster, more precise imaging for improved care in obstetrics and gynecology.
zacks.com
Read More
GE HealthCare Technologies: Still A Solid Long-Term Play
GE HealthCare Technologies, spun off from General Electric in 2023, has shown significant stock growth, outperforming the S&P 500 by a wide margin. Despite mixed financial performance, the company remains undervalued compared to competitors, with potential for further growth in a large, expanding market. Management's optimistic guidance for 2024 and beyond, coupled with strategic investments and partnerships, supports continued revenue and profit growth.
seekingalpha.com
Read More
GE HealthCare Invests $138 Million in Cork, Ireland Manufacturing Facility to Address Increasing Contrast Media Demand
CHALFONT ST. GILES, England--(BUSINESS WIRE)--GE HealthCare invests $138 million in Cork, Ireland manufacturing facility to address increasing contrast media demand.
businesswire.com
Read More
GE HealthCare named to 2025 Fortune World's Most Admired Companies™ list
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) has been named to 2025 Fortune World's Most Admired Companies™ list. The company has been recognized across several categories including the quality of management, products and services, innovation, value as a long-term investment, financial soundness, talent acquisition and retention, community and environmental responsibility, global business, and use of corporate assets. Being named to Fortune World's Most Admired Companies™ list for the.
businesswire.com
Read More
GEHC Stock Gains on the Collaborated Launch of Care Innovation Hub
GE HealthCare announces the launch of a Care Innovation Hub, a joint research collaboration with the University of California, San Francisco.
zacks.com
Read More
China External Cardiology Remote Monitors Market Outlook to 2033, with Key Companies Shenzhen Mindray Bio-Medical Electronics Co., Nihon Kohden and GE HealthCare Technologies
Dublin, Jan. 20, 2025 (GLOBE NEWSWIRE) -- The "China External Cardiology Remote Monitors Market Outlook to 2033" report has been added to ResearchAndMarkets.com's offering. The comprehensive databook report covers key market data on the Chinese External Cardiology Remote Monitors market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments for External Cardiology Remote Monitors The China External Cardiology Remote Monitors Market report provides key information and data on:
globenewswire.com
Read More
Reasons to Add GE HealthCare Stock to Your Portfolio Now
GEHC's continued focus on innovations, acquisitions and partnerships raises optimism about the stock.
zacks.com
Read More
GEHC Stock Gains on Long-Term Collaboration With Sutter Health
GE HealthCare announces a seven-year strategic collaboration with Sutter Health.
zacks.com
Read More
GEHC or PODD: Which Is the Better Value Stock Right Now?
Investors interested in Medical - Products stocks are likely familiar with GE HealthCare Technologies (GEHC) and Insulet (PODD). But which of these two stocks is more attractive to value investors?
zacks.com
Read More
Sutter Health and GE HealthCare enter strategic partnership to benefit patients, physicians and clinicians with advanced, AI-powered imaging
SACRAMENTO, Calif.--(BUSINESS WIRE)--Sutter Health and GE HealthCare (Nasdaq: GEHC) today announced a seven-year strategic enterprise partnership, known as a Care Alliance, that aims to increase access to innovative imaging services and create a more seamless and coordinated experience for clinicians and patients across the Sutter Health system. The long-term collaboration will increase access to essential diagnostic care across California, providing patients with advanced technology in their o.
businesswire.com
Read More
Here's Why GE HealthCare Technologies (GEHC) is a Strong Value Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
zacks.com
Read More
GE HealthCare Stock Gains After Jefferies Analysts Name It 'Franchise Pick'
GE HealthCare Technologies (GEHC) shares gained Wednesday after Jefferies analysts called the stock a “franchise pick” and made a bullish case for the company's diagnostic imaging business.
investopedia.com
Read More
Stock Of The Day: Where Will The GE HealthCare Rally End?
GE HealthCare Technologies Inc. GEHC shares are trading higher Wednesday. The stock was upgraded from Hold to Buy, while the price target was raised from $95 to $103 by Jefferies.
benzinga.com
Read More
Why GE HealthCare Technologies (GEHC) is a Top Stock for the Long-Term
Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.
zacks.com
Read More
United States External Cardiology Remote Monitors Market Outlook to 2033 Featuring Key Players, GE HealthCare, Shenzhen Mindray Bio-Medical Electronics, and Nihon Kohden
Dublin, Jan. 02, 2025 (GLOBE NEWSWIRE) -- The "United States External Cardiology Remote Monitors Market Outlook to 2033" report has been added to ResearchAndMarkets.com's offering. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - External Cardiology Remote Monitors
globenewswire.com
Read More
GEHC vs. PODD: Which Stock Is the Better Value Option?
Investors interested in stocks from the Medical - Products sector have probably already heard of GE HealthCare Technologies (GEHC) and Insulet (PODD). But which of these two companies is the best option for those looking for undervalued stocks?
zacks.com
Read More
5 Top AI-in-MedTech Stocks for Big Gains in 2025: MDT, BSX & More
Here we discuss five medical stocks - MDT, BSX, BDX, GEHC and TEM - incorporating AI in their workflows. These are likely to gain in 2025 as AI helps cut costs and improve patient care.
zacks.com
Read More
Why GE HealthCare Technologies (GEHC) is a Top Value Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
zacks.com
Read More
2025 Could Be GE HealthCare's Year With Emphasis On Efficiency And AI Broadens
GE HealthCare shares have surged nearly 27% since October 2023, driven by AI-driven strategies and innovation in healthcare diagnostics, despite some volatility in revenue growth. The bullish outlook for 2025 is supported by GEHC's AI advancements, expected sales and profitability improvements, and a significant backlog of $19.6 billion. AI-driven healthcare solutions are projected to enhance diagnostic accuracy, reduce treatment costs, and drive market growth, with GEHC positioned as a leader with numerous FDA-approved devices.
seekingalpha.com
Read More
Reasons to Retain GE HealthCare Stock in Your Portfolio Now
GEHC's continued focus on innovations, acquisitions and partnerships raises optimism about the stock.
zacks.com
Read More
GE HealthCare: Growth Acceleration In 2025 Can Drive Stock Higher
GE HealthCare Technologies is rated a buy due to strong growth prospects, a healthy backlog, and favorable valuation compared to peers. The company's revenue growth is supported by new product innovations, including the FDA-approved Flyrcado, and potential recovery in Chinese demand. Margins are expected to improve through cost optimization, volume leverage, and strategic pricing, with a medium-term EBIT margin target of high teens to 20%.
seekingalpha.com
Read More
GEHC Stock May Gain Following the Launches of Aurora and Clarify DL
GE HealthCare announces that Aurora will expand the range of CT procedures and Clarify DL will enhance SPECT image quality.
zacks.com
Read More
GE HealthCare Expands Its Effortless Recon DL Portfolio, Bringing Advanced Deep Learning Image Reconstruction to Clinicians Worldwide
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) unveiled three new advanced deep learning image processing and reconstruction solutions as a part of its Effortless Recon DL portfolio at the Radiological Society of North America (RSNA) 2024 Annual Meeting, in Chicago, IL. Understanding the need to improve operational efficiencies within radiology departments and the ongoing challenge of burnout experienced by clinicians, GE HealthCare developed the technologies to deliver exceptional imag.
businesswire.com
Read More
GEHC Stock May Gain From Potential FDA Clearance for CleaRecon DL
GE HealthCare announces the FDA submission of its CleaRecon DL technology to improve CBCT images.
zacks.com
Read More
GE HealthCare showcases commitment to sustainable innovation at RSNA 2024
CHICAGO--(BUSINESS WIRE)--As part of a companywide commitment to advance innovation that improves the health of patients and the planet, GE HealthCare (Nasdaq: GEHC) is highlighting several solutions with increased focus on sustainability at the Radiological Society of North America (RSNA) 2024 Annual Meeting, which is held Dec. 1-4 in Chicago, IL. “With a deep appreciation for the importance of sustainability, at GE HealthCare, we are managing our environmental footprint by integrating sustain.
businesswire.com
Read More
Trade Tracker: Stephanie Link sells Lam Research, GE Healthcare and buys more Gap, CrowdStrike
Stephanie Link, CIO at Hightower, joins CNBC's "Halftime Report" to reveal her latest portfolio moves.
youtube.com
Read More
GEHC Stock May Gain Following the Launch of Sonic DL for 3D Imaging
GE HealthCare announces the new Sonic DL for 3D, which will reduce scan times and provide faster, high-quality imaging for the majority of MR scans.
zacks.com
Read More
GE HealthCare to Acquire Remaining 50% Stake in Nihon Medi-Physics (NMP), a Leading Radiopharmaceutical Company in Japan, from Sumitomo Chemical
CHALFONT ST GILES, England--(BUSINESS WIRE)--GE HealthCare to acquire remaining 50% stake in Nihon Medi-Physics (NMP), a leading radiopharmaceutical company in Japan, from Sumitomo Chemical.
businesswire.com
Read More
GE HealthCare Unveils Sonic DL for 3D, Expanding Deep Learning Innovations in MRI
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today unveiled Sonic DL for 3Dii, the newest addition to its effortless imaging portfolio, designed to accelerate MRI scans across a wide range of clinical applications. Sonic DL for 3D builds on GE HealthCare's deep learning innovation legacy and the success of AIR Recon DL, which has helped over 34 million patients to date. Initially launched in 2023 for Cardiac MRI, Sonic DL provides up to 12 times scan acceleration while maintaining dia.
businesswire.com
Read More
GE HealthCare Highlights New Solutions Including AI-enabled Innovations to Drive Precision Care at RSNA 2024
CHICAGO--(BUSINESS WIRE)--At the Radiological Society of North America's (RSNA) 2024 Annual Meeting taking place from Dec. 1-4 in Chicago, GE HealthCare (Nasdaq: GEHC) will exhibit more than 40 innovations, including several key artificial intelligence (AI)-enabled technologies to optimize patient care and increase operational efficiencies. GE HealthCare products are designed to increase efficiency and help seamlessly integrate data to support precision care across multiple care pathways. These.
businesswire.com
Read More
GEHC Stock Up Following New Tie-Up to Boost Cancer Research and Care
The latest collaboration aims to provide new opportunities to improve cancer diagnosis using GE HealthCare's technology and enhance clinical workflow.
zacks.com
Read More
GEHC Stock May Gain Following the Launch of Pristina Via System
GE HealthCare announces the Pristina Via mammography system, which will help minimize repetitive tasks and streamline workflows for mammography technologists.
zacks.com
Read More
GE HealthCare unveils Pristina Via to streamline technologist workflow and improve patient-centered breast care
CHICAGO--(BUSINESS WIRE)--Today GE HealthCare announced the new Pristina Via™* mammography system designed to enhance the screening experience for both technologists and patients. Debuting at the Radiological Society of North America's 2024 Annual Meeting, this innovation provides mammography technologists with a suite of sophisticated tools that balance the demands of diagnostic accuracy and fast-paced workflows to facilitate more patient-centered breast care. Recent data from the American Soc.
businesswire.com
Read More
GEHC Stock May Gain on Its Enhanced OEC 3D Mobile CBCT C-Arm Portfolio
GE HealthCare announces the latest application additions to its OEC 3D mobile CBCT C-arm portfolio to improve clinician workflow and visualization during endoscopic bronchoscopy procedures.
zacks.com
Read More
GE HealthCare Announces Advanced Imaging Innovations for OEC 3D C-arm to Help Improve Precision Care in Practice of Interventional Pulmonology
CHICAGO--(BUSINESS WIRE)--GE HealthCare announces additional clinical applications now available as part of the OEC 3D mobile CBCT C-arm portfolio.
businesswire.com
Read More
GE HealthCare Guidance Was Good. The Stock Dropped Anyway.
GE HealthCare hosted an analyst event on Thursday. Solid guidance fell on deaf ears.
barrons.com
Read More
FDA clears XENOVIEW® 3T Chest Coil in GE HealthCare MRI Systems
Expands accessibility for institutions utilizing GE HealthCare MRI systems Expands accessibility for institutions utilizing GE HealthCare MRI systems
globenewswire.com
Read More
GEHC Stock Likely to Gain on Portrait Mobile Solution's Prospects
GE HealthCare's Portrait Mobile solution will provide continuous monitoring in post-surgery settings. It will also deliver informative alarms, advancing patient care while alleviating the burdens faced by clinicians.
zacks.com
Read More
GE HealthCare hosts 2024 Investor Day: focus on innovation to deliver precision care and drive growth
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) will host its Investor Day today at Nasdaq MarketSite in New York, NY. The event begins at 8:00 am ET / 7:00 am CT and can be viewed virtually here. Registration is required for in-person attendance. The event will feature presentations from GE HealthCare President and CEO Peter Arduini, GE HealthCare Vice President and CFO Jay Saccaro, and other members of the management team, who will discuss the company's vision and precision care strate.
businesswire.com
Read More
GE HealthCare and DeepHealth Collaborate to Advance AI in Imaging
GEHC and DeepHealth collaborate to develop AI-based imaging tools that can streamline workflow and help manage large imaging volumes without compromising diagnostic accuracy.
zacks.com
Read More
GEHC Stock Falls Despite FDA Clearance for SIGNA MAGNUS MRI System
GE Healthcare receives FDA clearance for its head-only SIGNA MAGNUS 3.0T MRI System.
zacks.com
Read More
RadNet Stock Pops on Earnings, GE HealthCare Partnership
Radnet Inc (NASDAQ:RDNT) stock is soaring, last seen up 24% to trade at $89.11 at last glance, after the company reported better-than-expected earnings and revenue for the third quarter.
schaeffersresearch.com
Read More
GE HealthCare and RadNet Forge Collaboration to Transform Imaging Systems and Accelerate the Adoption of Artificial Intelligence (AI) with SmartTechnology™
CHICAGO--(BUSINESS WIRE)--Today, GE HealthCare (Nasdaq: GEHC) and DeepHealth, Inc., a global leader in AI-powered health informatics and a wholly-owned subsidiary of RadNet, Inc. (Nasdaq: RDNT), announced a strategic collaboration to further the innovation, commercialization, and adoption of AI in imaging. Together, the two companies aim to develop SmartTechnology™ solutions that harness the transformative power of AI to address key challenges across the imaging value chain, including helping i.
businesswire.com
Read More
GE HealthCare Technologies Inc. Prices Secondary Offering of 13,281,302 Shares
CHICAGO--(BUSINESS WIRE)--GE HealthCare Technologies Inc. (Nasdaq: GEHC) (the “Company” or “GE HealthCare”) announced today the pricing of the previously announced secondary underwritten public offering (the “Offering”) of 13,281,302 shares of its common stock (the “GEHC Shares”). GE HealthCare is not selling any shares of common stock and will not receive any proceeds from the sale of the GEHC Shares in the Offering or from the debt-for-equity exchange (as described below). Prior to the closin.
businesswire.com
Read More
GE HealthCare Technologies Inc. Commences Secondary Offering of 13,281,302 Shares
CHICAGO--(BUSINESS WIRE)--GE HealthCare Technologies Inc. (Nasdaq: GEHC) (the “Company” or “GE HealthCare”) announced today the launch of a secondary underwritten public offering (the “Offering”) of 13,281,302 shares of its common stock (the “GEHC Shares”). GE HealthCare is not selling any shares of common stock and will not receive any proceeds from the sale of the GEHC Shares in the Offering or from the debt-for-equity exchange (as described below). Prior to the closing of the Offering, GE Ae.
businesswire.com
Read More
GE HealthCare: Light Up With Growth Indicators In Medical Tech, While Undervalued
GE Healthcare Technologies gets a buy rating, agreeing with today's Wall Street and SA analyst consensus. The firm's recent Q3 results showed growth indicators in multiple segments, despite headwinds from China, and will be crucial in supplying in-demand contrast dyes used in medical imaging. The stock is still undervalued on multiple fronts (EV/EBITDA, P/E), despite the share price trending above its moving average.
seekingalpha.com
Read More
Calls of the Day: KLA Corp, Lam Research, ASML Holding, Target and GE Healthcare
The Investment Committee debate the latest Calls Of The Day.
youtube.com
Read More
From Spin-Off To Standout: GE HealthCare Is Pretty Impressive
GE HealthCare's spin-off has unlocked valuation potential, allowing each former GE segment to thrive independently and attract market-specific growth. The company's Q3 showed steady revenue and margin gains, driven by operational efficiencies and growth in high-demand medical technologies. With advancements in AI and diagnostics, GE HealthCare is well-positioned to capture market share, though growth faces temporary headwinds in China.
seekingalpha.com
Read More
GE HealthCare Q3 Earnings Beat Estimates, Sales Meet, Net Margin Up
GEHC's third-quarter results witness declining segmental revenues in imaging and ultrasound, offset by strong Pharmaceutical Diagnostics performance. The bottom line improves on better pricing.
zacks.com
Read More